By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Koningin Wilhelminalaan 22

Driebergen    3972 EX  The Netherlands
Phone: 31-655-764-221 Fax:


Company News
Patent Position Of Merus' MeMo® Mouse Strengthened by Ruling of European Patent Office 9/18/2014 10:54:54 AM
ProBioGen AG And Merus Sign Deal On GlymaxX® ADCC Enhancement Technology 3/4/2014 9:46:09 AM
Merus Granted European Patent on MeMo®, a Transgenic Mouse for Generating the Building Blocks of Therapeutic Human Bispecific Antibodies 10/23/2013 10:25:18 AM
Merus Lands $42 Million Series B 10/3/2013 6:48:02 AM
Merus Presents Preclinical Data on Its Novel Bispecific Antibody MCLA-117 at European Hematology Association 2013 6/17/2013 8:56:07 AM
SUPPRESTEM Consortium Led by Merus Receives $7.7 Million FP7 Grant From the European Union 5/28/2013 9:52:28 AM
Merus Further Expands R&D Capacity 3/7/2013 11:13:41 AM
Merus Achieves Milestone With Novartis AG (NVS) Option 2/7/2013 7:08:33 AM
OcellO and Merus Sign Agreement for Screening Bispecific Cancer Antibodies 1/14/2013 11:05:46 AM
Merus Selects Clinical Candidate for the Treatment of Acute Myeloid Leukemia (AML) 1/7/2013 11:54:22 AM